Brief: Venus Medtech Hangzhou Says On April 8, Venusp-Valve Received CE Marking Under Medical Devices Regulation & Marketed In Europe
11/04/2022 13:04
April 11 (Reuters) - Venus Medtech Hangzhou Inc 2500.HK :
* ON APRIL 8, VENUSP-VALVE RECEIVED CE MARKING UNDER MEDICAL
DEVICES REGULATION & MARKETED IN EUROPE
Source text for Eikon: ID:nHKS70Y13P
Further company coverage: 2500.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Venus Medtech (Hangzhou)
See all newsBrief: Venus Medtech Hangzhou To Issue 184.5 Million Shares And HK$379.7 Million Convertible Bonds
Brief: Venus Medtech Hangzhou Says Six-Month Revenue Rmb135.5 Million
Brief: Venus Medtech Hangzhou Says Liqiao Ma Resigns As Executive Director
Brief: Venus Medtech Hangzhou Logs FY Revenue RMB 306.8 Mln
Brief: Venus Medtech Says Unaware Of Any Info Needing Disclosure To Avoid False Market